Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Fuji
Novartis
Chinese Patent Office
Merck
Federal Trade Commission
AstraZeneca
Cerilliant
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,886,134

« Back to Dashboard

Summary for Patent: 3,886,134
Title: Analogues of angiotensin II
Abstract:Novel hepta- and octapeptides of the formula: ##SPC1## Wherein R is hydrogen, succinyl, L-aspartyl, L-sarcosyl, L-seryl, succinamyl, or D- or L-asparaginyl and R.sub.1 is an L-alanine, L- or D-leucine, glycine or L-isoleucine residue upon intravenous infusion to animals inhibit blood pressure response to angiotensin amide.
Inventor(s): Sipos; Frank (Norwich, NY), Pals; Donald T. (Oxford, NY), Denning; George S. (Norwich, NY)
Assignee: Morton-Norwich Products, Inc. (Norwich, NY)
Application Number:05/043,595
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 3,886,134

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 3,886,134

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 333986 ➤ Subscribe
Austria A483471 ➤ Subscribe
Belgium 767784 ➤ Subscribe
Canada 940120 ➤ Subscribe
Switzerland 555807 ➤ Subscribe
Germany 2127393 ➤ Subscribe
Denmark 145740 ➤ Subscribe
Spain 391701 ➤ Subscribe
Finland 53305 ➤ Subscribe
France 2125248 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Chinese Patent Office
Deloitte
Cantor Fitzgerald
Daiichi Sankyo
Cipla
Harvard Business School
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot